🇺🇸 FDA
Pipeline program

Expanded , Activated NK cells

DSRB 2014/00452

Phase 2 mab active

Quick answer

Expanded , Activated NK cells for Ewing Sarcoma is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Ewing Sarcoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials